Amdocs (NASDAQ:DOX) Raised to Buy at Wall Street Zen

Amdocs (NASDAQ:DOXGet Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued on Saturday.

DOX has been the subject of a number of other reports. Weiss Ratings reissued a “hold (c)” rating on shares of Amdocs in a research note on Tuesday, January 27th. Stifel Nicolaus dropped their target price on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday. Bank of America cut their price target on Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a research note on Wednesday, November 12th. Barclays reduced their price target on Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a research report on Wednesday. Finally, Wolfe Research reiterated a “peer perform” rating on shares of Amdocs in a report on Thursday, November 13th. Three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $92.33.

View Our Latest Analysis on DOX

Amdocs Stock Up 3.1%

Shares of Amdocs stock opened at $73.34 on Friday. The firm has a market cap of $7.92 billion, a price-to-earnings ratio of 14.19, a P/E/G ratio of 1.26 and a beta of 0.40. The stock has a 50-day simple moving average of $80.15 and a 200-day simple moving average of $82.39. Amdocs has a 52-week low of $70.24 and a 52-week high of $95.41. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.06 and a quick ratio of 1.17.

Amdocs (NASDAQ:DOXGet Free Report) last issued its quarterly earnings data on Tuesday, February 3rd. The technology company reported $1.81 earnings per share for the quarter, topping analysts’ consensus estimates of $1.75 by $0.06. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The business had revenue of $1.16 billion during the quarter, compared to analysts’ expectations of $1.15 billion. During the same period in the previous year, the company earned $1.66 earnings per share. Amdocs’s revenue for the quarter was up 4.1% on a year-over-year basis. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. On average, equities research analysts expect that Amdocs will post 6.21 earnings per share for the current fiscal year.

Institutional Trading of Amdocs

Several institutional investors have recently added to or reduced their stakes in the company. Pzena Investment Management LLC grew its stake in Amdocs by 82.6% during the fourth quarter. Pzena Investment Management LLC now owns 12,037,015 shares of the technology company’s stock worth $969,100,000 after buying an additional 5,443,766 shares in the last quarter. Alliancebernstein L.P. boosted its position in shares of Amdocs by 32.1% during the 3rd quarter. Alliancebernstein L.P. now owns 2,359,779 shares of the technology company’s stock worth $193,620,000 after acquiring an additional 573,349 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd increased its stake in Amdocs by 500.0% in the third quarter. Clal Insurance Enterprises Holdings Ltd now owns 420,000 shares of the technology company’s stock valued at $34,461,000 after acquiring an additional 350,000 shares during the last quarter. Arbejdsmarkedets Tillaegspension acquired a new position in Amdocs during the fourth quarter valued at approximately $24,272,000. Finally, Nordea Investment Management AB lifted its stake in Amdocs by 18.0% during the second quarter. Nordea Investment Management AB now owns 1,879,023 shares of the technology company’s stock worth $170,803,000 after purchasing an additional 287,235 shares during the last quarter. 92.02% of the stock is currently owned by institutional investors.

Amdocs Company Profile

(Get Free Report)

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.

Recommended Stories

Analyst Recommendations for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.